Activation map based individualized planning for deep brain stimulation

Patent metadata

Field	Value
Publication number	US-10159836-B2
Application number	US-201715858028-A
Country	US
Kind code	B2
Filing date	Dec 29, 2017
Priority date	Dec 8, 2013
Publication date	Dec 25, 2018
Grant date	Dec 25, 2018

Abstract

Example apparatus and methods plan and control neuro-modulation of a distributed multi-region network in a brain. A location for a deep brain stimulation (DBS) electrode that participates in activating a combination of white matter pathways associated with the network is selected. The location is selected based on a pre-implantation image of the brain and a probabilistic activation model of the network. An initial stimulation parameter for DBS to be applied through the DBS electrode is selected based on a post-implantation image of the brain and the probabilistic activation model of the network. A modified stimulation parameter for DBS being applied through the DBS electrode is selected based on the initial stimulation parameter, a local field potential measured in the distributed multi-region network in response to DBS applied using the initial stimulation parameter, the probabilistic activation model of the distributed multi-region network, and the post-implantation image of the brain.

First claim

What is claimed is:

1. A method, comprising:
accessing a population-based therapeutic tractography map of a human brain;
accessing a pre-operative medical image of a brain of a patient;
creating a patient-specific therapeutic tractography map for the brain of the patient based, at least in part, on the population-based therapeutic tractography map and the pre-operative medical image;
identifying a desired location for a deep brain stimulation (DBS) electrode in the brain of the patient based, at least in part, on the patient-specific therapeutic tractography map for the brain of the patient and a desired DBS therapeutic effect;
identifying an actual post-operative location of the DBS electrode from a post-operative medical image of the brain of the patient,
identifying a parameter for a DBS stimulation to be performed to achieve the desired DBS therapeutic effect using the DBS electrode, where the parameter depends on the actual post-operative location of the DBS electrode, the therapeutic tractography map for the brain of the patient, and the desired therapeutic effect, where the desired therapeutic effect depends, at least in part, on activation of two or more target areas via a combination of two or more white matter pathways; and
controlling a DBS apparatus to apply the DBS through the DBS electrode according to the parameter.

2. The method of claim 1 , comprising controlling the DBS apparatus to record a local field potential (LFP) at a stimulation site associated with the DBS electrode or at an activation site associated with the desired therapeutic effect, where the LFPs are produced in response to applying the DBS through the DBS electrode according to the parameter.

3. The method of claim 2 , comprising selectively adjusting the parameter based, at least in part, on the LFP at the stimulation site or the LFP at the activation site.

4. The method of claim 3 , where the parameter is adjusted substantially in real-time.

5. The method of claim 1 , where the population-based therapeutic tractography map is based on probabilistic tractography including whole-brain analysis and seed-to-target analysis.

6. The method of claim 1 , where the pre-operative medical image is a magnetic resonance imaging (MRI) image.

7. The method of claim 6 , where the MRI image is a diffusion tensor image.

8. The method of claim 1 , where the desired DBS therapeutic effect is treatment of depression, treatment of treatment resistant depression (TRD), treatment of obsessive compulsive disorder (OCD), treatment of epilepsy, treatment of Parkinson's disease, or treatment of Alzheimer's disease.

9. The method of claim 1 , where the desired DBS therapeutic effect is treatment of treatment resistant depression (TRD) and where the desired location for the DBS electrode is a position that activates a pathway from the bilateral forceps to the medial frontal cortex, a position that activates a pathway from the cingulate bundle to the cingulate cortex, or a position that activates a pathway from the descending subcortical midline fibers to the subcortical nuclei.

10. An apparatus for controlling patient-specific selective activation of a combination of targeted white matter pathways to treat a neurological condition using deep brain stimulation (DBS), comprising:
a first circuit configured to access a population-based therapeutic tractography map of a human brain;
a second circuit configured to access a pre-operative medical image of a brain of a patient;
a third circuit configured to create a patient-specific therapeutic tractography map for the brain of the patient based, at least in part, on the population-based therapeutic tractography map and the pre-operative medical image;
a fourth circuit configured to identify a desired location for a deep brain stimulation (DBS) electrode in the brain of the patient based, at least in part, on the patient-specific therapeutic tractography map for the brain of the patient and a desired DBS therapeutic effect;
a fifth circuit configured to identify an actual post-operative location of the DBS electrode from a post-operative medical image of the brain of the patient; and
a sixth circuit configured to identify a parameter for a DBS stimulation to be performed to achieve the desired DBS therapeutic effect using the DBS electrode, where the parameter depends on the actual post-operative location of the DBS electrode, the therapeutic tractography map for the brain of the patient, and the desired therapeutic effect, where the desired therapeutic effect depends, at least in part, on activation of two or more target areas via a combination of two or more white matter pathways.

11. A computer-readable storage device storing computer-executable instructions that, in response to execution, cause a deep brain stimulation (DBS) system to perform operations for controlling patient-specific selective activation of a combination of targeted white matter pathways to treat a neurological condition, comprising:
creating a patient-specific therapeutic tractography map of a patient brain based, at least in part, on a pre-operative medical image of the patient brain and a population-based therapeutic tractography map of the human brain, where the population-based therapeutic tractography map of the human brain is based, at least in part, on activation volume tractography derived from a neural response to a specific electrical stimulation parameter associated with a neurostimulation;
identifying one or more desired DBS electrode placements and one or more stimulation parameters for treatment of the neurological condition using DBS based, at least in part, on the patient-specific therapeutic tractography map, where the one or more DBS electrode placements and the one or more stimulation parameters facilitate activation of axons located in the combination of white matter pathways;
selectively modifying the one or more stimulation parameters based, at least in part, on actual locations of the one or more DBS electrodes as determined from a post-operative medical image of the patient brain and on the patient-specific therapeutic tractography map; and
controlling the DBS system to apply the DBS through the DBS electrode according to the one or more stimulation parameters.

12. The computer-readable storage device of claim 11 , where the pre-operative medical image of the patient brain is a magnetic resonance imaging (MRI) image.

13. The computer-readable storage device of claim 12 , where the MRI image is a diffusion tensor image.

14. The computer-readable storage device of claim 11 , where the neurological condition is depression, treatment resistant depression (TRD), epilepsy, Parkinson's disease, Alzheimer's disease, or obsessive compulsive disorder (OCD).

15. The computer-readable storage device of claim 11 , where the neurological condition is treatment resistant depression (TRD) and the combination of white matter pathways includes a pathway from the bilateral forceps to the medial frontal cortex, a pathway from the cingulate bundle to the cingulate cortex, or a pathway from the descending subcortical midline fibers to the subcortical nuclei.

16. The computer-readable storage device of claim 11 , where the neurological condition is treatment resistant depression (TRD) and the combination of white matter pathways includes a pathway from the bilateral forceps to the medial frontal cortex, a pathway from the cingulate bundle to the cingulate cortex, and a pathway from the descending subcortical midline fibers to the subcortical nuclei.

17. The computer-readable storage device of claim

Assignees

• Univ Case Western Reserve

Inventors

• Mcintyre Cameron
• Riva-Posse Patricio
• Choi Ki Sueng
• Chaturvedi Ashutosh
• Mayberg Helen
• Tagliati Michele
• Cheung Tyler

Classifications

• A61N1/0534

  Electrodes for deep brain stimulation · CPC title

• A61N1/36096

  Mood disorders, e.g. depression, anxiety or panic disorder · CPC title

• A61N1/36064

  Epilepsy · CPC title

• A61N1/36067

  Movement disorders, e.g. tremor or Parkinson disease (stimulating motor muscle A61N1/36003) · CPC title

• A61N1/36139 Primary

  with automatic adjustment · CPC title